Advances in diagnosis and prognosis of bacteraemia, bloodstream infection, and sepsis using machine learning: A comprehensive living literature review

Abstract

Background:

Blood-related infections are a significant concern in healthcare. They can lead to serious medical complications and even death if not promptly diagnosed and treated. Throughout time, medical research has sought to identify clinical factors and strategies to improve the management of these conditions. The increasing adoption of electronic health records has led to a wealth of electronically available medical information and predictive models have emerged as invaluable tools. This manuscript offers a detailed survey of machine-learning techniques used for the diagnosis and prognosis of bacteraemia, bloodstream infections, and sepsis shedding light on their efficacy, potential limitations, and the intricacies of their integration into clinical practice.

Methods:

This study presents a comprehensive analysis derived from a thorough search across prominent databases, namely EMBASE, Google Scholar, PubMed, Scopus, and Web of Science, spanning from their inception dates to October 25, 2023. Eligibility assessment was conducted independently by investigators, with inclusion criteria encompassing peer-reviewed articles and pertinent non-peer-reviewed literature. Clinical and technical data were meticulously extracted and integrated into a registry, facilitating a holistic examination of the subject matter. To maintain currency and comprehensiveness, readers are encouraged to contribute manuscript suggestions and/or reports for integration into this living registry.

Results:

While machine learning (ML) models exhibit promise in advanced disease stages such as sepsis, early stages remain underexplored due to data limitations. Biochemical markers emerge as pivotal predictors during early stages such as bacteraemia, or bloodstream infections, while vital signs assume significance in sepsis prognosis. Integrating temporal trend information into conventional machine learning models appears to enhance performance. Unfortunately, sequential deep learning models face challenges, showing minimal performance improvements and significant drops in external datasets, potentially due to learning missing patterns within the scarce data available rather than understanding disease dynamics. Real-life implementation receives limited attention, as meeting design requirements proves challenging within existing healthcare infrastructure. The data collected in an event-based fashion during clinical practice is insufficient to fully harness the potential of these data-hungry models. Despite limitations, opportunities abound in leveraging flexible models and exploiting real-time non-invasive data collection technologies such as wearable devices or microneedles. Addressing research gaps in early disease stages, harnessing patient history data often underused, and embracing continual diagnostics beyond treatment initiation are crucial for improving healthcare decision-making support and adoption across the entire management pathway.

Conclusions:

This comprehensive survey illuminates the landscape of ML applications in blood-related infection management, offering insights for future research and clinical practice. Implementing clinical ML-based clinical decision support systems requires balancing research with practical considerations. Current methodologies often lead to complex models lacking transparency and practical validation. Integration into healthcare systems faces regulatory, privacy, and trust challenges. Clear presentations and adherence to standards are essential to boost confidence in machine learning models for real-world healthcare applications.